Table 2 Major groups of diseases stratified for sex and age at death, comparison between patients with MG and matched controls.
Age at death | Male patients (n = 100) | Male controls (n = 500) | p | Female patients (n = 149) | Female controls (n = 745) | p | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Respiratory tract disease | ||||||||||||
0–29 years | 0/2 | 0/10 | 1/4 (25.0) | 0/14 | 0.05 | |||||||
30–49 years | 3/6 (50.0) | 1/25 (4.0) | 0.003* | 4/22 (18.2) | 4/50 (8.0) | 0.21 | ||||||
50–69 years | 12/36 (33.3) | 14/127 (11.0) | 0.001* | 14/48 (29.2) | 24/179 (13.4) | 0.009* | ||||||
⩾70 years | 20/56 (35.7) | 89/338 (26.3) | 0.15 | 16/75 (21.3) | 128/502 (25.5) | 0.44 | ||||||
Total | 35/100 (35.0) | 104/500 (20.8) | 0.002* | 35/149 (23.5) | 156/745 (20.9) | 0.49 | ||||||
Cardiac disease | ||||||||||||
0–29 years | 0/2 | 0/10 | 0/4 | 1/14 (7.1) | 0.58 | |||||||
30–49 years | 0/6 | 8/25 (32.0) | 0.11 | 2/22 (9.1) | 6/50 (12.0) | 0.72 | ||||||
50–69 years | 7/36 (19.4) | 66/127 (52.0) | 0.001* | 7/48 (14.6) | 53/179 (29.6) | 0.036* | ||||||
⩾70 years | 22/56 (39.3) | 179/338 (53.0) | 0.06 | 34/75 (45.3) | 227/502 (45.2) | 0.99 | ||||||
Total | 29/100 (29.0) | 253/500 (50.6) | <0.001* | 43/149 (28.9) | 287/745 (38.5) | 0.026* | ||||||
Malignant disease | ||||||||||||
0–29 years | 0/2 | 0/10 | 0/4 | 3/14 (21.4) | 0.31 | |||||||
30–49 years | 0/6 | 3/25 (12.0) | 0.37 | 1/22 (4.5) | 23/50 (46.0) | 0.001* | ||||||
50–69 years | 4/36 (11.1) | 36/127 (28.3) | 0.034* | 5/48 (10.4) | 93/179 (52.0) | <0.001* | ||||||
⩾70 years | 7/56 (12.5) | 72/338 (21.3) | 0.13 | 5/75 (6.7) | 109/502 (21.7) | 0.002* | ||||||
Total | 11/100 (11.0) | 111/500 (22.2) | 0.011* | 11/149 (7.4) | 228/745 (30.6) | <0.001* | ||||||
Cerebrovascular disease | ||||||||||||
0–29 years | 0/2 | 0/10 | 0/4 | 1/14 (7.1) | 0.58 | |||||||
30–49 years | 1/6 (16.7) | 2/25 (8.0) | 0.52 | 0/22 | 5/50 (10.0) | 0.12 | ||||||
50–69 years | 1/36 (2.8) | 15/127 (11.8) | 0.11 | 3/48 (6.3) | 17/179 (9.5) | 0.48 | ||||||
⩾70 years | 10/56 (17.9) | 66/338 (19.5) | 0.77 | 10/75 (13.3) | 121/502 (24.1) | 0.038* | ||||||
Total | 12/100(12.0) | 83/500 (16.6) | 0.25 | 13/149 (8.7) | 144/745 (19.3) | 0.002* |
The fraction, as well as the percentage (in brackets), shows the occurrence of the disease compared with all deceased individuals of the same sex who died in the same time period. * Pearson x2 tests were used. Statistical significance.